Celynn Lim is an accomplished professional in regulatory affairs, currently serving as Senior Manager for Global Regulatory Affairs in Rare Diseases at Ipsen since March 2022, where responsibilities include acting as EU Lead and International Lead for an ultra-rare disease asset. Prior to Ipsen, Celynn worked at Servier as a Regional Regulatory Affairs Manager, overseeing regulatory projects in the Asia-Pacific region and managing early-phase clinical development projects. Additionally, Celynn held the Head of Department position for Regulatory Affairs in Malaysia and Brunei, leading a team and coordinating product submissions in the ASEAN region. Experience includes roles in regulatory affairs at Boehringer Ingelheim and a background in clinical research at Merck and Lundbeck, complemented by a Master of Pharmacy degree from the University of Strathclyde.
This person is not in any teams
This person is not in any offices